Boston Scientific To Participate In Piper Jaffray 2015 Healthcare Conference
Get Alerts BSX Hot Sheet
Join SI Premium – FREE
MARLBOROUGH, Mass., Nov. 17, 2015 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Piper Jaffray 27th Annual Healthcare Conference on December 1, in New York City.
Jeff Mirviss, senior vice president and president, Peripheral Interventions and Susie Lisa, vice president, Investor Relations, will participate in a 25-minute question-and-answer session regarding the company with the host analyst beginning at approximately 8:00 a.m. ET.
A live webcast of the question-and-answer session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com. Registration at least 15 minutes prior to the scheduled start time is encouraged to ensure a timely connection.
A replay of the webcast will be accessible at investors.bostonscientific.com beginning approximately one hour following the completion of the question-and-answer session.
About Boston ScientificBoston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.
|
CONTACTS |
|
|
Media: |
Investors: |
|
Kelly Leadem |
Susie Lisa, CFA |
|
508-683-5543 (office) |
508- 683-5565 (office) |
|
Media Relations |
Investor Relations |
|
Boston Scientific Corporation |
Boston Scientific Corporation |
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-piper-jaffray-2015-healthcare-conference-300179758.html
SOURCE Boston Scientific
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Piper Jaffray, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share